Firefly Neuroscience (AIFF) EBITDA (2016 - 2025)
Historic EBITDA for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$2.7 million.
- Firefly Neuroscience's EBITDA rose 3771.11% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.8 million, marking a year-over-year decrease of 1967.97%. This contributed to the annual value of -$10.1 million for FY2024, which is 22664.07% down from last year.
- Firefly Neuroscience's EBITDA amounted to -$2.7 million in Q3 2025, which was up 3771.11% from -$1.6 million recorded in Q2 2025.
- In the past 5 years, Firefly Neuroscience's EBITDA registered a high of $493116.0 during Q2 2023, and its lowest value of -$4.7 million during Q3 2022.
- Over the past 5 years, Firefly Neuroscience's median EBITDA value was -$1.3 million (recorded in 2021), while the average stood at -$1.6 million.
- As far as peak fluctuations go, Firefly Neuroscience's EBITDA soared by 31435.58% in 2021, and later plummeted by 482061.83% in 2022.
- Quarter analysis of 5 years shows Firefly Neuroscience's EBITDA stood at -$1.3 million in 2021, then grew by 24.99% to -$1.0 million in 2022, then crashed by 54.76% to -$1.6 million in 2023, then crashed by 119.27% to -$3.4 million in 2024, then rose by 22.7% to -$2.7 million in 2025.
- Its EBITDA stands at -$2.7 million for Q3 2025, versus -$1.6 million for Q2 2025 and -$2.1 million for Q1 2025.